JSL Health Capital
VC Fund
Washington, United States
JSL Health Capital is an investment firm that funds, partners, and builds transformational healthcare companies. JSL Health Capital invests in and builds the intersection of healthcare, AI, and data. JSL Health Capital was founded in 2022 and was headquartered in Washington, District of Columbia.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries JSL Health Capital invests in
Stages JSL Health Capital invests in
Countries JSL Health Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Turkeltaub
|
|||
|
Lekan Wang
|
|||
3 more contacts available
Investment Focus
Industry
- Health Care 6 (67%)
- Medical 3 (33%)
- Medical Device 2 (22%)
- Artificial Intelligence 2 (22%)
- mHealth 1 (11%)
Stage
- Series A 3 (33%)
- Series B 2 (22%)
- Funding Round 2 (22%)
- Seed 1 (11%)
- Series C 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alex Turkeltaub
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 0 | Find email | |
|
Lekan Wang
General Partner
|
General Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Connie Health
|
Connie Health empowers older Americans to make confident, worry-free healthcare decisions. | $40M / Series B / Jun 18, 2026 | |
Beacon Biosignals
|
Beacon Biosignals is a neurotechnology company focused on bringing precision neuroscience into clinical trials and treatments for brain- and sleep-related disorders. The company’s core offering includes an FDA-cleared wearable device (the Waveband headband) that captures high-fidelity EEG during sleep and wake states, combined with an AI-drivenanalytics platform that processes millions of hours of neural data to extract biomarkers of brain function. Its end-to-end solution supports pharmaceutical and biotech clients by providing tools for patient stratification, dose-response monitoring, and early-stage disease progression, enabling trials to be more precise and efficient. | $11M / Series B / Apr 06, 2026 | |
Radial
|
Radial provides new medical treatments for mental conditions including treatments like neuromodulation and rapid acting medications. | $50M / Series A / Dec 09, 2025 | |
Synfini
|
Synfini, Inc., a privately held Menlo Park, California-based company, is a pioneer in agile chemistry. Its advanced, automated molecular discovery platform is transforming drug discovery through integrated neuro-symbolic AI, discovery-focused robotic automation, and world-class chemistry data. The patented Synfini platform includes automatedchemical synthesis technologies from SRI International. As a commercial enterprise Synfini will provide accelerated molecular discovery to drug hunters and pharmaceutical companies worldwide. | $8.9M / Jul 07, 2025 | |
General Medicine
|
General Medicine provides accessible healthcare services, including virtual visits, lab testing, imaging, referrals, and prescriptions to cater to patient needs. The organization is committed to supporting patients throughout their healthcare journey, whether through local specialists or in-house clinicians for various health concerns. | $32M / Series A / May 22, 2025 | |
Network Bio
|
Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $17M / Seed / Feb 27, 2025 | |
Bicycle Health
|
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become anaddiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients.Ankit Gupta established it in San Francisco, California in 2017. | $16.5M / Jan 29, 2025 | |
Precision Neuroscience
|
Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable ofprocessing large amounts of data.The company was founded in 2021 and is based in New York. | $102M / Series C / Nov 06, 2024 | |
Rippl Care
|
Rippl, a mental health organization, is committed to assisting seniors who suffer from dementia and other neurocognitive disorders. | $23M / Series A / Oct 02, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does JSL Health Capital invest in?
JSL Health Capital invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact JSL Health Capital?
Public channels for JSL Health Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at JSL Health Capital?
The team at JSL Health Capital includes Alex Turkeltaub (Founder and Managing Partner) and Lekan Wang (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
